Committee hears bill to allow subscription pharmacy programs such as RxPass in Texas

House Bill 24 02 would clarify that pharmacy subscription programs (for example, RxPass) that charge a monthly fee for access to a defined list of generics should not be included in Medicaid’s calculation of a pharmacy’s usual and customary (U&C) price where the subscription price is not publicly available in the community market. Supporters told the committee that many states allow subscription‑style pharmacy programs and that RxPass is available in 48 other states; Amazon Pharmacy and AARP Texas both testified in support.